|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Diabetic Retinopathy | |||||
| Retinal Neovascularization | |||||
| Diabetes Mellitus | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Neovascularization, Pathologic | |||||
| 3 | More general conditions related to this trial | ||||
| Cardiovascular Diseases | |||||
| Diabetes Complications | |||||
| Diabetic Angiopathies | |||||
| Endocrine System Diseases | |||||
| Eye Diseases | |||||
| Glucose Metabolism Disorders | |||||
| Metabolic Diseases | |||||
| Metaplasia | |||||
| Pathologic Processes | |||||
| Retinal Diseases | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Blue-Green Argon Laser Treatment | |||||
| Red Krypton Laser Treatment | |||||
| 5 | Sponsors listed in this trial | ||||
| National Eye Institute (NEI) | |||||